CD8A and neoplasm: In addition to VEGF/VEGFR inhibitors, the intrafocal injection of an oncolytic virus (OV) can effectively infect tumor cells and induce tumor lysis, promoting a tumor-specific immune response by inducing the CD8+ T-cell infiltration and upregulation of immune-related gene signatures.